Cita APA

Driessen, J., Wit, F. D., Herrera, A. F., Zinzani, P. L., LaCasce, A. S., Cole, P. D., . . . Kersten, M. J. (2024). Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: A propensity score–matched analysis.

Citación estilo Chicago

Driessen, Julia, et al. Brentuximab Vedotin and Chemotherapy in Relapsed/refractory Hodgkin Lymphoma: A Propensity Score–matched Analysis. 2024.

Cita MLA

Driessen, Julia, et al. Brentuximab Vedotin and Chemotherapy in Relapsed/refractory Hodgkin Lymphoma: A Propensity Score–matched Analysis. 2024.